Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Neutral B cell antigen epitope polypeptide of encephalitis b virus E protein and uses thereof

A technology of Japanese encephalitis virus and antigenic epitope, applied in the field of molecular immunology, can solve problems such as weak heat resistance

Inactive Publication Date: 2008-12-31
HARBIN VETERINARY RES INST CHINESE ACADEMY OF AGRI SCI
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The virus has weak resistance to heat and can be inactivated at 56°C for 30 minutes or 100°C for 2 minutes, but it is highly resistant to low temperature and drying

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Neutral B cell antigen epitope polypeptide of encephalitis b virus E protein and uses thereof
  • Neutral B cell antigen epitope polypeptide of encephalitis b virus E protein and uses thereof
  • Neutral B cell antigen epitope polypeptide of encephalitis b virus E protein and uses thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Example 1 Overlapping (over lapping) polypeptide fusion expression series JEV E protein antigen polypeptide fragments and indirect ELISA screening

[0027] According to the amino acid sequence of JEVE protein, a series of polypeptides are designed, which overlap each other and cover the full length of JEVE protein. According to the amino acid sequence of each polypeptide, a pair of DNA strands are designed and synthesized, and the DNA strands are inserted into the expression vector and GST for fusion expression. A series of recombinant proteins fused and expressed with JEV neutralizing monoclonal antibody were applied for analysis to analyze the neutralizing epitope of JEV E protein. The specific process is as follows:

[0028] Design of polypeptide sequence→synthesis of DNA chain encoding polypeptide sequence→construction of polypeptide fusion expression vector→induction expression→expression of fusion protein affinity chromatography purification→expression product an...

Embodiment 2

[0040] Example 2 Synthesis of Japanese encephalitis virus JEVE protein neutralizing B cell epitope

[0041] According to the amino acid sequence of the E protein neutralizing B cell epitope, the solid-phase peptide synthesis technology is applied, and the automatic peptide synthesizer or artificial peptide synthesis method is adopted. The solid-phase resin adopts Fmoc-protected amino acid Wang resin or other resins. After the resin is swollen with DMF and piperidine glue Fmoc-protected, according to the amino acid sequence sequence, Fmoc-protected amino acids are added, and the acylation reaction is carried out in the presence of HBTU. After the acylation reaction is completed, after washing, the second Fmoc-amino acid is added for acylation reaction and washed. In such a cycle, a complete polypeptide chain is synthesized sequentially from the C-terminus of the polypeptide sequence to the N-terminus. After the synthesis is completed, select an appropriate reagent according to...

Embodiment 3

[0043] Example 3 Chemical Modification of Japanese Encephalitis Virus JEV E Protein B Cell Antigen Epitope

[0044] The polypeptide fragment synthesized according to the method of Example 2 has a natural amino modification at its N-terminus and a natural carboxyl modification at its C-terminus.

[0045] N-terminal acetylation modification method: Synthesize the polypeptide according to the above introduction until the coupling of the last Fmoc protected amino acid is completed, and remove the N-terminal Fmoc protecting group, and then perform the following operations. Dissolve 150 μl acetic anhydride and 20 μL EIPEA in 4.8 ml DMF, mix well and cool in an ice bath. Then add the above mixed solution into the peptide synthesis reaction tube and react for 5 minutes. Then wash with 5ml DMF and dichloromethane (DCM) twice, each time for 5min. After drying with nitrogen gas, the removal, cleavage, purification and identification of side chain protecting groups were carried out acco...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to View More

Abstract

The invention discloses a polypeptides epitope in Japanese encephalitis virus E protein neutralizing B cell, also discloses the application of the polypeptides epitope in the prevention, treatment and diagnosis of Japanese encephalitis, belonging to the field of molecular immunology. The amino acid sequence of the polypeptides epitope disclosed in the invention is shown in SEQ ID NO: 1 or SEQ ID NO: 2. After being used as immunogen or vaccine immune animal organisms, the JEV E protein neutralizing B cell polypeptides epitope of the invention can produce neutralizing antibody against Japanese encephalitis virus, and can neutralize the Japanese encephalitis virus in vivo or in vitro so as to prevent the virus infecting animal organisms. The polypeptides epitope of the invention can immunise animals if being self-connected or inter-connected with carriers; the anti-peptide antibodies or the anti-Japanese encephalitis virus antibodies produced after the immunising of animals can neutralize the Japanese encephalitis virus in vitro and in vivo and generate immune protection.

Description

technical field [0001] The present invention relates to antigenic epitope polypeptides, especially to Japanese encephalitis virus JEV E protein neutralizing B cell antigenic epitope polypeptides, and the present invention also relates to the application of the antigenic epitope polypeptides in preventing and diagnosing Japanese encephalitis virus, In the field of molecular immunology. Background technique [0002] Japanese encephalitis is an important mosquito-borne zoonotic disease caused by Japanese encephalitis virus (JEV). The virus was first isolated from the brain tissue of patients in Japan in 1953, so it is called Japanese encephalitis virus, and the disease caused by it is called Japanese encephalitis B in Japan. In my country, the virus was first isolated in 1940. In order to distinguish it from Japanese encephalitis, it was named Japanese encephalitis, or Japanese encephalitis for short. Worldwide, there are 30,000-50,000 JE cases every year, about 25%-30% die, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K7/06C12N15/40A61K39/12G01N33/569G01N33/53A61P31/14
CPCY02A50/30
Inventor 华荣虹步志高童光志
Owner HARBIN VETERINARY RES INST CHINESE ACADEMY OF AGRI SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com